PSNL Personalis Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PSNL

Price (delayed)

$12.07

Market cap

$1.26B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.02

Enterprise value

$1.22B

?
Relative Growth: Rel. Growth: 15
Relative Strength: Rel. Strength: 88
Relative Valuation: Rel. Valuation: 7
Relative Profitability: Rel. Profitability: 10

Personalis, Inc. is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing operations globally and ...

Highlights
The debt has declined by 9% year-on-year and by 2.6% since the previous quarter
The equity rose by 23% YoY but it fell by 2.5% QoQ
Personalis's EPS has increased by 18% YoY but it has decreased by 12% from the previous quarter
The gross profit has plunged by 69% YoY and by 44% from the previous quarter
The gross margin has dropped by 59% year-on-year and by 40% since the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.personalis.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of PSNL

PSNL stock price

How has the Personalis stock price performed over time
Intraday
11.97%
1 week
9.93%
1 month
104.58%
1 year
134.37%
YTD
51.63%
QTD
89.48%

Financial performance

How have Personalis's revenue and profit performed over time
Revenue
$64.52M
Gross profit
$8.85M
Operating income
-$102.52M
Net income
-$95.55M
Gross margin
13.7%
Net margin
-148.1%
PSNL's operating margin has shrunk by 103% YoY and by 26% QoQ
The gross profit has plunged by 69% YoY and by 44% from the previous quarter
The gross margin has dropped by 59% year-on-year and by 40% since the previous quarter
PSNL's operating income has dropped by 53% year-on-year and by 16% since the previous quarter

Price vs fundamentals

How does PSNL's price correlate with its fundamentals

Growth

What is Personalis's growth rate over time

Valuation

What is Personalis stock price valuation
P/E
N/A
P/B
4.96
P/S
19.49
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.93
Personalis's EPS has increased by 18% YoY but it has decreased by 12% from the previous quarter
The stock's price to book (P/B) is 177% more than its 5-year quarterly average of 1.6 and 53% more than its last 4 quarters average of 2.9
The equity rose by 23% YoY but it fell by 2.5% QoQ
The stock's price to sales (P/S) is 93% more than its last 4 quarters average of 9.0
PSNL's revenue is down by 25% YoY and by 7% QoQ

Efficiency

How efficient is Personalis business performance
Personalis's ROS has plunged by 51% YoY and by 27% from the previous quarter
The return on assets has declined by 12% since the previous quarter but it is up by 5% year-on-year
PSNL's ROIC is down by 12% since the previous quarter but it is up by 7% year-on-year
Personalis's return on equity has decreased by 11% QoQ but it has increased by 11% YoY

Dividends

What is PSNL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PSNL.

Financial health

How did Personalis financials performed over time
The company's total assets rose by 19% YoY but it fell by 2.6% QoQ
PSNL's total liabilities is up by 7% YoY but it is down by 3.2% QoQ
The debt is 88% smaller than the equity
The debt to equity has contracted by 25% YoY
The equity rose by 23% YoY but it fell by 2.5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.